Literature DB >> 22695765

Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery.

Matthew C Schwartz1, Lisa M Sullivan, Andrew C Glatz, Elizabeth Rand, Pierre Russo, David J Goldberg, Jonathan J Rome, Meryl S Cohen.   

Abstract

Hepatic fibrosis is an important complication after Fontan surgery in patients with single-ventricle congenital heart disease. Few reports of hepatic histology in these patients exist, and sinusoidal fibrosis has been described. We aimed to characterize fibrosis at liver biopsy procedure in patients with previous Fontan surgery and to identify patient variables associated with the degree of fibrosis. All patients who had previous Fontan surgery and who subsequently underwent liver biopsy at our institution between January 1990 and July 2010 were identified. For each biopsy specimen, portal and sinusoidal fibrosis were graded and medical records reviewed. Biopsy specimens from 13 patients were examined; the median time from Fontan surgery to liver biopsy procedure was 16.9 years (range 6.9-25). At the most recent biopsy procedure, 12 patients (92 %) had evidence of portal fibrosis, including 1 patient with portal-based cirrhosis. Thirteen patients (100 %) had at least some degree of sinusoidal fibrosis, including 1 patient with centrilobular-based cirrhosis. Lower platelet count was associated with greater degree of portal fibrosis by ordinal regression (odds ratio 0.84, P = 0.04), and patients with no or mild portal fibrosis had significantly higher platelet counts compared with those with moderate or severe portal disease (278 ± 78 K vs. 160 ± 46 K, P = 0.005). Four patients underwent serial biopsy procedures; portal fibrosis was progressed in 3 patients, and sinusoidal fibrosis was progressed in 3 patients. After Fontan surgery, portal and sinusoidal fibrosis are common at liver biopsy and can progress over time. Lower platelet count may represent a marker of portal-based disease in these patients.

Entities:  

Mesh:

Year:  2012        PMID: 22695765     DOI: 10.1007/s00246-012-0402-9

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  9 in total

1.  Hepatic pathology may develop before the Fontan operation in children with functional single ventricle: an autopsy study.

Authors:  Matthew C Schwartz; Lisa Sullivan; Meryl S Cohen; Pierre Russo; Anitha S John; Rong Guo; Marta Guttenberg; Elizabeth B Rand
Journal:  J Thorac Cardiovasc Surg       Date:  2011-09-28       Impact factor: 5.209

2.  The liver in heart failure; relation of anatomical, functional, and circulatory changes.

Authors:  S SHERLOCK
Journal:  Br Heart J       Date:  1951-07

Review 3.  Liver disease in the patient with Fontan circulation.

Authors:  Fred M Wu; Chinweike Ukomadu; Robert D Odze; Anne Marie Valente; John E Mayer; Michael G Earing
Journal:  Congenit Heart Dis       Date:  2011-03-28       Impact factor: 2.007

4.  Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis.

Authors:  L E Adinolfi; M G Giordano; A Andreana; M F Tripodi; R Utili; G Cesaro; E Ragone; E Durante Mangoni; G Ruggiero
Journal:  Br J Haematol       Date:  2001-06       Impact factor: 6.998

5.  Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma.

Authors:  Amir A Ghaferi; Grover M Hutchins
Journal:  J Thorac Cardiovasc Surg       Date:  2005-06       Impact factor: 5.209

6.  Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

Authors:  Carolin Lackner; Gerd Struber; Bernadette Liegl; Sebastian Leibl; Petra Ofner; Csilla Bankuti; Bernd Bauer; Rudolf E Stauber
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

7.  Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study.

Authors:  T J Kendall; B Stedman; N Hacking; M Haw; J J Vettukattill; A P Salmon; R Cope; N Sheron; H Millward-Sadler; G R Veldtman; J P Iredale
Journal:  J Clin Pathol       Date:  2007-10-26       Impact factor: 3.411

8.  Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations.

Authors:  Robert P Myers; Raimondo Cerini; Raymond Sayegh; Richard Moreau; Claude Degott; Didier Lebrec; Samuel S Lee
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

9.  Hepatic changes in the failing Fontan circulation.

Authors:  Christoph H Kiesewetter; Nick Sheron; Joseph J Vettukattill; Nigel Hacking; Brian Stedman; Harry Millward-Sadler; Marcus Haw; Richard Cope; Anthony P Salmon; Muthukumaran C Sivaprakasam; Tim Kendall; Barry R Keeton; John P Iredale; Gruschen R Veldtman
Journal:  Heart       Date:  2006-09-27       Impact factor: 5.994

  9 in total
  28 in total

1.  Serial evaluation of hepatic function profile after Fontan operation.

Authors:  R Kaulitz; P Haber; E Sturm; J Schäfer; M Hofbeck
Journal:  Herz       Date:  2013-05-08       Impact factor: 1.443

Review 2.  MR assessment of abdominal circulation in Fontan physiology.

Authors:  Shi-Joon Yoo; Milan Prsa; Daryl Schantz; Lars Grosse-Wortmann; Mike Seed; Tae Kyoung Kim; Rachel Wald; Rajiv Chaturvedi
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-22       Impact factor: 2.357

3.  An Observation from Liver Biopsies Two Decades Post-Fontan.

Authors:  William N Evans; Ruben J Acherman; Leigh C Reardon; Alvaro Galindo; Abraham Rothman; Michael L Ciccolo; Sergio A Carrillo; Brody J Winn; Noel S Yumiaco; Humberto Restrepo
Journal:  Pediatr Cardiol       Date:  2016-05-09       Impact factor: 1.655

4.  Importance of dynamic central venous pressure in Fontan circulation.

Authors:  JeongHye Kim; Seiko Kuwata; Clara Kurishima; Yoichi Iwamoto; Hirotaka Ishido; Satoshi Masutani; Hideaki Senzaki
Journal:  Heart Vessels       Date:  2018-01-08       Impact factor: 2.037

5.  Fontan Outcomes and Pulmonary Blood Flow at Birth.

Authors:  William N Evans; Ruben J Acherman; Leigh C Reardon; Michael L Ciccolo; Alvaro Galindo; Abraham Rothman; Brody J Winn; Noel S Yumiaco; Humberto Restrepo
Journal:  Pediatr Cardiol       Date:  2015-07-18       Impact factor: 1.655

6.  MELD-XI Scores Correlate with Post-Fontan Hepatic Biopsy Fibrosis Scores.

Authors:  William N Evans; Ruben J Acherman; Michael L Ciccolo; Sergio A Carrillo; Alvaro Galindo; Abraham Rothman; Brody J Winn; Noel S Yumiaco; Humberto Restrepo
Journal:  Pediatr Cardiol       Date:  2016-06-14       Impact factor: 1.655

7.  Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening.

Authors:  T Ackerman; A Geerts; H Van Vlierberghe; J De Backer; K François
Journal:  Pediatr Cardiol       Date:  2018-07-21       Impact factor: 1.655

8.  Transvenous hepatic biopsy in stable Fontan patients undergoing cardiac catheterization.

Authors:  William N Evans; Brody J Winn; Noel S Yumiaco; Alvaro Galindo; Abraham Rothman; Ruben J Acherman; Humberto Restrepo
Journal:  Pediatr Cardiol       Date:  2014-05-10       Impact factor: 1.655

9.  Effect of Fontan operation on liver stiffness in children with single ventricle physiology.

Authors:  Frank W DiPaola; Kurt R Schumacher; Caren S Goldberg; Joshua Friedland-Little; Aishwarya Parameswaran; Jonathan R Dillman
Journal:  Eur Radiol       Date:  2016-10-17       Impact factor: 5.315

10.  Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function.

Authors:  Kathleen E Simpson; Amir Esmaeeli; Geetika Khanna; Francis White; Yumirle Turnmelle; Pirooz Eghtesady; Umar Boston; Charles E Canter
Journal:  J Heart Lung Transplant       Date:  2013-10-25       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.